Trial of Sequential Medications AfteR TNFi Failure in Juvenile Idiopathic Arthritis

NCT06654882 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

400

Enrollment

OTHER

Sponsor class

Conditions

Polyarticular Course Juvenile Idiopathic Arthritis (JIA)

Interventions

DRUG: TNFi (Tumor Necrosis Factor inhibitor) medication
DRUG: Abatacept
DRUG: Tocilizumab
DRUG: Tofacitinib

Sponsor

Duke University

Collaborators

[object Object]